According to Chugai Pharmaceutical's latest financial reports the company's current earnings are โฌ7.19 Billion. In 2023 the company made an earning of โฌ2.89 Billion a decrease over its 2022 earnings that were of โฌ3.76 Billion. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | โฌ2.99 B | 3.52% |
2023 | โฌ2.89 B | -23.07% |
2022 | โฌ3.76 B | 8.82% |
2021 | โฌ3.45 B | 32.69% |
2020 | โฌ2.60 B | 47.31% |
2019 | โฌ1.76 B | 72.77% |
2018 | โฌ1.02 B | 27.77% |
2017 | โฌ0.80 B | 24.88% |
2016 | โฌ0.64 B | -4.23% |
2015 | โฌ0.66 B | 2% |
2014 | โฌ0.65 B | -8.93% |
2013 | โฌ0.72 B | -16.63% |
2012 | โฌ0.86 B | 29.38% |
2011 | โฌ0.66 B | -5.93% |
2010 | โฌ0.71 B | -19.02% |
2009 | โฌ0.87 B |